PhylisIWarkentinMD

PubMed

• A robust quality infrastructure is key to safe and effective delivery of immune effector cells: how FACT-finding can help.
  Kevin J Curran, Sarah Nikiforow, Carlos Bachier, Yen-Michael Hsu, Marcela V Maus, Basem William, Kara Wacker, Phyllis Warkentin, Helen E Heslop, David Maloney, Philip ...> ;Blood Advances. 2024 Feb 27
• 7 citations
  Paving the Road for Chimeric Antigen Receptor T Cells: American Society for Transplantation and Cellular Therapy 80/20 Task Force Consensus on Challenges and Solutions...
  Sarah Nikiforow, Matthew J Frigault, Noelle V Frey, Rebecca A Gardner, Krishna V Komanduri, Miguel-Angel Perales, Partow Kebriaei, Phyllis Irene Warkentin, Marcelo Pas...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 3 citations
  Standardization, workforce development and advocacy in cell and gene therapies: a summary of the 2020 Regenerative Medicine InterCHANGE.
  Ian K. McNiece, Kara K. Wacker, Joanne Kurtzberg, Phyllis I. Warkentin> ;Cytotherapy. 2021 Oct 1
• 4 citations
  Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
  Jack W. Hsu, Bronwen E. Shaw, Soyoung Kim, Brent R. Logan, Jennifer A. Sees, Dennis L. Confer, Michael A. Pulsipher, Nirali N. Shah, Galen E. Switzer, Muneer H. Abidi,...> ;Biology of Blood and Marrow Transplantation. 2020 Jun 1
• 5 citations
  Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model
  Charles F. LeMaistre, Kara K. Wacker, Luke P. Akard, A. Samer Al-Homsi, Dennis A. Gastineau, Kamar Godder, Michael Lill, George B. Selby, Amir Steinberg, Judy M. Ander...> ;Biology of Blood and Marrow Transplantation. 2019 Nov 1
• 5 citations
  Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.
  Sachit Patel, Don W. Coulter, Alfred C. Grovas, Bruce Geoffrey Gordon, James Harper, Phyllis I. Warkentin, James L. Wisecarver, Warren G. Sanger, Peter F. Coccia> ;Journal of Pediatric Hematology/oncology. 2014 Aug 1
• 8 citations
  Successful unrelated cord blood transplantation for homozygous α-thalassemia
  Burak Gumuscu, Elizabeth I. Thompson, Alfred C. Grovas, Terrence L. Zach, Phyllis I. Warkentin, Peter F. Coccia> ;Journal of Pediatric Hematology/oncology. 2013 Oct 1
• 8 citations
  Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use
  Dumrul Gülen, S. Maas, H. Julius, Phyllis I. Warkentin, Holly C. Britton, Ibrahim Younos, J. Senesac, Samuel J. Pirruccello, James E. Talmadge> ;International Immunopharmacology. 2012 May 1
• 42 citations
  Autologous Peripheral Blood Stem Cell Transplantation in Children with Refractory or Relapsed Lymphoma: Results of Children’s Oncology Group Study A5962
  Richard E. Harris, Amanda Termuhlen, Lynette M. Smith, James C. Lynch, Michael M. Henry, Sherrie L. Perkins, Thomas G. Gross, Phyllis I. Warkentin, Adrianna Vlachos, L...> ;Biology of Blood and Marrow Transplantation. 2011 Feb 1
• 14 citations
  Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors
  Dumrul Gülen, Fuminori Abe, Sarah Maas, Elizabeth C. Reed, Kenneth H. Cowan, Samuel J. Pirruccello, James L. Wisecarver, Phyllis I. Warkentin, Matt Northam, Orhan Turk...> ;International Immunopharmacology. 2008 Dec 20
• 4 citations
  Terminology and labeling of cellular products: 1. Standards
  Paul Ashford, Pat Distler, Adrian P. Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbac...> ;Bone Marrow Transplantation. 2007 Dec 1
• 4 citations
  Standards for the terminology and labeling of cellular therapy products.
  Paul Ashford, Pat Distler, Adrian P. Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbac...> ;Journal of Clinical Apheresis. 2007 Oct 1
• 6 citations
  ISBT 128 implementation plan for cellular therapy products
  Paul Ashford, Pat Distler, Adrian P. Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbac...> ;Journal of Clinical Apheresis. 2007 Oct 1
• 5 citations
  ISBT 128 implementation plan for cellular therapy products.
  Paul Ashford, Pat Distler, Adrian P. Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbac...> ;Transfusion. 2007 Jul 1
• 6 citations
  Standards for the Terminology and Labeling of Cellular Therapy Products
  Paul Ashford, Pat Distler, Adrian P. Gee, Alan Lankester, Stella Larsson, Irene Feller, Kathy Loper, Derwood Pamphilon, Leigh Poston, Fran Rabe, Ineke Slaper-Cortenbac...> ;Transfusion. 2007 Jul 1
• 59 citations
  Mitoxantrone and Cytarabine Induction, High-Dose Cytarabine, and Etoposide Intensification for Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia: C...
  Robert J. Wells, Mary T. Adams, Todd A. Alonzo, Robert J. Arceci, Jonathan D. Buckley, Allen Buxton, Kathryn E. Dusenbery, Alan S. Gamis, Margaret Masterson, Terry A. ...> ;Journal of Clinical Oncology. 2003 Aug 1
• 199 citations
  Isolated Hepatocyte Transplantation in an Infant With a Severe Urea Cycle Disorder
  Simon Horslen, Timothy C. McCowan, Timothy C. Goertzen, Phyllis I. Warkentin, Hung Bo Cai, Stephen C. Strom, Ira J. Fox> ;Pediatrics. 2003 Jun 1
• 2 citations
  Hematopoietic stem and progenitor cell transplants: regulation and accreditation
  Phyllis I. Warkentin> ;Pediatric Transplantation. 2003 Apr 1
• 34 citations
  Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT).
  Phyllis I. Warkentin> ;Cytotherapy. 2003 Jan 1
• 6 citations
  Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
  Manabu Hirai, Drake LaFace, S. N. Robinson, Linda S. Kelsey, Robert G. Johnson, Shu Fen Wen, Phyllis I. Warkentin, Kevin Mills, Mei Vaillancourt, Jennifer Chavez, Cher...> ;Cancer Gene Therapy. 2001 Dec 1
• 86 citations
  Outcomes of Treatment of Children and Adolescents With Recurrent Non-Hodgkin’s Lymphoma and Hodgkin’s Disease With Dexamethasone, Etoposide, Cisplatin, Cytarabine, and...
  Nathan L. Kobrinsky, Richard Sposto, Narayan R. Shah, James R. Anderson, Cynthia DeLaat, Margaret Morse, Phyllis I. Warkentin, Gerald S. Gilchrist, Mervyn D. Cohen, Do...> ;Journal of Clinical Oncology. 2001 May 1
• 11 citations
  FAHCT accreditation: common deficiencies during on-site inspections
  Phyllis I. Warkentin, L. Nick, Elizabeth J. Shpall> ;Cytotherapy. 2000 Mar 1
• 7 citations
  Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.
  Shantaram S. Joshi, K. Miller, John D. Jackson, Phyllis I. Warkentin, Anne Kessinger> ;Cytotherapy. 2000 Jan 1
• 4 citations
  Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique
  Samuel J. Pirruccello, Cynthia Page, Michael R. Bishop, B. Letheby, Phyllis I. Warkentin, John D. Jackson, Anne Kessinger> ;Cytotherapy. 1999 Jan 1
• 36 citations
  Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products
  Ana G. Ageitos, Michelle L. Varney, P. J. Bierman, Julie M. Vose, Phyllis I. Warkentin, James E. Talmadge> ;Bone Marrow Transplantation. 1999 Jan 1
• Join now to see all